BIO-key International, Inc.
BKYI
$0.78
$0.0314.14%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.14M | 1.14M | 2.18M | 1.83M | 1.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.14M | 1.14M | 2.18M | 1.83M | 1.82M |
| Cost of Revenue | 465.10K | 262.30K | 299.60K | 1.92M | 1.48M |
| Gross Profit | 1.68M | 879.00K | 1.88M | -95.50K | 340.50K |
| SG&A Expenses | 1.61M | 1.94M | 1.78M | 2.04M | 1.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.73M | 2.80M | 2.69M | 4.55M | 3.78M |
| Operating Income | -580.40K | -1.65M | -508.90K | -2.72M | -1.97M |
| Income Before Tax | -739.00K | -1.67M | -510.30K | -2.65M | -1.84M |
| Income Tax Expenses | -- | -- | -- | -276.80K | -200.00 |
| Earnings from Continuing Operations | -739.00K | -1.67M | -510.30K | -2.37M | -1.84M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -739.00K | -1.67M | -510.30K | -2.37M | -1.84M |
| EBIT | -580.40K | -1.65M | -508.90K | -2.72M | -1.97M |
| EBITDA | -480.00K | -1.55M | -407.10K | -6.35M | -1.90M |
| EPS Basic | -0.39 | -1.00 | -0.32 | -4.24 | -3.22 |
| Normalized Basic EPS | -0.24 | -0.63 | -0.20 | -- | -2.20 |
| EPS Diluted | -0.39 | -1.00 | -0.32 | -4.24 | -3.22 |
| Normalized Diluted EPS | -0.24 | -0.63 | -0.20 | -- | -2.20 |
| Average Basic Shares Outstanding | 1.89M | 1.66M | 1.62M | 560.30K | 570.80K |
| Average Diluted Shares Outstanding | 1.89M | 1.66M | 1.62M | 560.30K | 570.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |